Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Research Report 2024

Publication ID:

PB502250517

Publication Date:

February 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Methylated RNA Immunoprecipitation Sequencing uses sepecific antibodies (m6A, m5C, etc.) to modify the targeted RNAs. After the modification, Immunoprecipitation is then induced to sepecifically enrich & collect those antibody-modified RNAs. Then, use high-throughput sequencing to detect the modified RNAs.
The global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The study of RNA modifications, such as N6-methyladenosine (m6A), has gained significant attention in the fields of molecular biology and genomics. This increased interest in epitranscriptomics has driven demand for techniques like MeRIP-Seq to investigate RNA modifications. MeRIP-Seq has primarily been used in academic and research settings to understand the functional roles of RNA modifications. Research institutions and universities have been key customers for MeRIP-Seq reagents and services. While still in the early stages, there is growing interest in applying MeRIP-Seq and RNA modification analysis to clinical research, including cancer biology and neurological disorders. This presents opportunities for companies to develop diagnostic tools and therapies based on RNA modifications.
This report aims to provide a comprehensive presentation of the global market for Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq).
Report Scope
The Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Epigentek
Illumina
Merck
Cloudseq Biotech Inc.
CD Genomics
Arraystar
LC Sciences
Segment by Type
Whole Transcriptome Sequencing
Incomplete Transcriptome Sequencing
Segment by Application
Cell Differentiation Study
Developmental Biology Study
Disease Development Study
Heat Shock Response Study
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Whole Transcriptome Sequencing
1.2.3 Incomplete Transcriptome Sequencing
1.3 Market by Application
1.3.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cell Differentiation Study
1.3.3 Developmental Biology Study
1.3.4 Disease Development Study
1.3.5 Heat Shock Response Study
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Perspective (2019-2030)
2.2 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Growth Trends by Region
2.2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Region (2019-2024)
2.2.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Region (2025-2030)
2.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Dynamics
2.3.1 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Industry Trends
2.3.2 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Drivers
2.3.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Challenges
2.3.4 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Revenue
3.1.1 Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Revenue (2019-2024)
3.1.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Players (2019-2024)
3.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue
3.4 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Concentration Ratio
3.4.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue in 2023
3.5 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Key Players Head office and Area Served
3.6 Key Players Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product Solution and Service
3.7 Date of Enter into Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Breakdown Data by Type
4.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Type (2019-2024)
4.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Type (2025-2030)
5 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Breakdown Data by Application
5.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Application (2019-2024)
5.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
6.2 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024)
6.4 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
7.2 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024)
7.4 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
8.2 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2019-2024)
8.4 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
9.2 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024)
9.4 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
10.2 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024)
10.4 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Epigentek
11.1.1 Epigentek Company Detail
11.1.2 Epigentek Business Overview
11.1.3 Epigentek Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.1.4 Epigentek Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.1.5 Epigentek Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.2.4 Illumina Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.3.4 Merck Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Cloudseq Biotech Inc.
11.4.1 Cloudseq Biotech Inc. Company Detail
11.4.2 Cloudseq Biotech Inc. Business Overview
11.4.3 Cloudseq Biotech Inc. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.4.4 Cloudseq Biotech Inc. Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.4.5 Cloudseq Biotech Inc. Recent Development
11.5 CD Genomics
11.5.1 CD Genomics Company Detail
11.5.2 CD Genomics Business Overview
11.5.3 CD Genomics Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.5.4 CD Genomics Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.5.5 CD Genomics Recent Development
11.6 Arraystar
11.6.1 Arraystar Company Detail
11.6.2 Arraystar Business Overview
11.6.3 Arraystar Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.6.4 Arraystar Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.6.5 Arraystar Recent Development
11.7 LC Sciences
11.7.1 LC Sciences Company Detail
11.7.2 LC Sciences Business Overview
11.7.3 LC Sciences Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.7.4 LC Sciences Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.7.5 LC Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Epigentek
Illumina
Merck
Cloudseq Biotech Inc.
CD Genomics
Arraystar
LC Sciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂